Empagliflozin Enhances Hepatic Glucose Production and Reduces Total-Body Norepinephrine Turnover Rate: A Randomized Trial. Abdelgani S, Khattab A, Adams JM, Al-Mulla F, et al. Diabetes 2025;74:1480-1488.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Abdelgani S, Khattab A, Adams JM, Al-Mulla F, et al. Empagliflozin Enhances Hepatic Glucose Production and Reduces Total-Body Norepinephrine Turnover Rate: A Randomized Trial. Diabetes 2025;74:1480-1488.
PMID: 40668643